NTF3

neurotrophin 3, the group of Neurotrophins

Basic information

Region (hg38): 12:5432108-5521536

Links

ENSG00000185652NCBI:4908OMIM:162660HGNC:8023Uniprot:P20783AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NTF3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NTF3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
4
clinvar
5
missense
12
clinvar
12
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 12 1 4

Variants in NTF3

This is a list of pathogenic ClinVar variants found in the NTF3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-5494276-T-C not specified Uncertain significance (Jan 12, 2024)3202553
12-5494366-A-C not specified Uncertain significance (Apr 04, 2024)3301237
12-5494407-A-G not specified Uncertain significance (Oct 26, 2022)2320095
12-5494423-G-A not specified Uncertain significance (May 31, 2022)2346403
12-5494432-A-T not specified Uncertain significance (Feb 12, 2024)3202550
12-5494440-G-A Hirschsprung disease, susceptibility to, 1 Uncertain significance (Apr 01, 2015)190264
12-5494441-G-A Aganglionic megacolon Benign (-)599416
12-5494476-A-G not specified Uncertain significance (Dec 02, 2021)2385191
12-5494484-C-T Benign (Sep 14, 2018)717685
12-5494540-G-A not specified Uncertain significance (Aug 14, 2023)2618280
12-5494564-T-C not specified Uncertain significance (Jun 06, 2023)2547542
12-5494572-A-C not specified Uncertain significance (Aug 11, 2021)2242992
12-5494620-C-G not specified Uncertain significance (Jan 10, 2023)2475465
12-5494621-G-A not specified Uncertain significance (Jul 20, 2021)2239021
12-5494651-G-T not specified Uncertain significance (Sep 29, 2023)3202551
12-5494760-C-T Benign (May 24, 2018)745236
12-5494803-G-A not specified Uncertain significance (Aug 22, 2023)2621433
12-5494815-G-A not specified Uncertain significance (Jun 16, 2024)3301238
12-5494823-C-T Benign (Aug 20, 2018)780146
12-5494832-G-A Likely benign (Jul 01, 2022)2642596
12-5494901-A-G Benign (Jul 13, 2018)784229

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NTF3protein_codingprotein_codingENST00000423158 289425
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9320.0679125744031257470.0000119
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.741081720.6280.00001231736
Missense in Polyphen4086.1460.46433829
Synonymous0.4236973.60.9370.00000554540
Loss of Function3.08113.00.07719.99e-7114

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00006210.0000615
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.00001760.0000176
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Seems to promote the survival of visceral and proprioceptive sensory neurons.;
Pathway
PI3K-Akt signaling pathway - Homo sapiens (human);Neurotrophin signaling pathway - Homo sapiens (human);Ras signaling pathway - Homo sapiens (human);MAPK signaling pathway - Homo sapiens (human);Brain-Derived Neurotrophic Factor (BDNF) signaling pathway;MAPK Signaling Pathway;PI3K-Akt Signaling Pathway;Signal Transduction;role of erk5 in neuronal survival pathway;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;NTF3 activates NTRK2 (TRKB) signaling;Signaling by NTRK2 (TRKB);Signaling by NTRKs;BDNF;SHP2 signaling;GPCR signaling-G alpha i;Signaling by Receptor Tyrosine Kinases;Neurotrophic factor-mediated Trk receptor signaling;p75(NTR)-mediated signaling;Trk receptor signaling mediated by the MAPK pathway (Consensus)

Recessive Scores

pRec
0.530

Intolerance Scores

loftool
0.448
rvis_EVS
-0.07
rvis_percentile_EVS
48.12

Haploinsufficiency Scores

pHI
0.352
hipred
Y
hipred_score
0.786
ghis
0.550

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.619

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Ntf3
Phenotype
behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype; muscle phenotype;

Gene ontology

Biological process
activation of MAPK activity;positive regulation of receptor internalization;signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway;cell-cell signaling;nervous system development;peripheral nervous system development;memory;positive regulation of cell population proliferation;regulation of signaling receptor activity;positive regulation of phospholipase C activity;positive regulation of phosphatidylinositol 3-kinase signaling;nerve development;positive regulation of cell migration;activation of protein kinase B activity;positive regulation of peptidyl-serine phosphorylation;nerve growth factor signaling pathway;regulation of apoptotic process;negative regulation of neuron apoptotic process;regulation of neuron differentiation;neuron projection morphogenesis;positive regulation of peptidyl-tyrosine phosphorylation;negative regulation of peptidyl-tyrosine phosphorylation;modulation of chemical synaptic transmission;positive chemotaxis;induction of positive chemotaxis;activation of GTPase activity;positive regulation of actin cytoskeleton reorganization
Cellular component
extracellular region;extracellular space;synaptic vesicle;axon;dendrite;cytoplasmic vesicle
Molecular function
signaling receptor binding;neurotrophin receptor binding;protein binding;growth factor activity;chemoattractant activity